Carbon monoxide may improve effectiveness of antibiotics: study

Image
Press Trust of India Washington
Last Updated : Feb 22 2018 | 2:05 PM IST
Carbon monoxide may significantly improve the effectiveness of antibiotics, according to a study which may open up novel ways to fight antibiotic resistance.
The study led by researchers at Georgia State University in the US paired carbon monoxide with the antibiotic metronidazole.
The researchers found carbon monoxide enhanced the efficacy of the antibiotic against H pylori, a type of bacteria that infects the stomach and causes peptic ulcers.
"We found that if you administer carbon monoxide together with an antibiotic called metronidazole, it can sensitise bacteria towards the same antibiotic by 25-fold," said Binghe Wang from Georgia State.
"It makes the bacteria much, much more sensitive to the antibiotic," he said.
"We always hear about the discussions of drug resistance. When we have drug resistance, its not because these bacteria will not respond to antibiotics anymore," said Wang.
"Most of the time, it means there is decreased sensitivity. If you can resensitise bacteria or sensitise them, then that would allow you to either use a smaller amount of antibiotic or use the same amount that would kill many, many more bacteria," he said.
Carbon monoxide is infamous for its toxicity at high concentrations, but it also has promising potential as a medical gas, researchers said.
Produced naturally in the human body, carbon monoxide is essential for survival and plays an important role in reducing inflammation, promoting cell proliferation and regulating cellular immune response to pathogens, they said.
Studies have found carbon monoxide has antimicrobial effects.
In the study published in the journal Organic Letters, the researchers developed a prodrug system that releases three components: carbon monoxide, an antibiotic (metronidazole) and a fluorescent molecule used to monitor the release of carbon monoxide.
A prodrug is the precursor of a drug and must undergo a chemical conversion before becoming an active pharmacological agent.
This prodrug system has a three-reaction sequence and becomes active when placed in water, which sets the reaction in motion.
They studied H pylori bacteria in a culture dish and compared the effect of only the antibiotic metronidazole against the bacteria versus the prodrug system with metronidazole and carbon monoxide combined.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 22 2018 | 2:05 PM IST

Next Story